Literature DB >> 33731099

Perceptions and experiences of lifestyle interventions in women with polycystic ovary syndrome (PCOS), as a management strategy for symptoms of PCOS.

Susan Arentz1, Caroline A Smith2, Jason Abbott3, Alan Bensoussan2.   

Abstract

BACKGROUND: The international clinical practice guidelines for PCOS emphasize diet and exercise as first-line management of clinical signs and symptoms. This study aimed to describe the patterns, perceptions and experiences of lifestyle interventions for women in the community with PCOS.
METHOD: An electronic survey of 493 members of two PCOS consumer support groups, collected by cloud-based Survey Monkey, described women's types and patterns of diet and exercise, experiences and perceptions of effectiveness. Women were recruited from the Polycystic Ovary Association of Australia (POSAA) and from the Facebook group, PCOS University Research Group. Associations between participants perceptions of effectiveness, and diet types and exercise patterns were assessed using logistic regression. Response bias for the POSAA group was assessed with a continuum of resistance model.
RESULTS: 91% of POSAA members and 311 Facebook group members aged 16-50 years responded to the survey. Nearly all women reported adjusting their dietary and exercise practices with the aim to improve their health and/or PCOS (82% and 73% respectively), however less than 13% reported achievement of health goals (12.2% and 8.1% respectively). Low carbohydrate, high protein diets, and vigorous activity were associated with self-perceived effectiveness (r.0.16, p < 0.01; r.0.15 p < 0.01 and r.0.2 p < 0.01 respectively). Barriers for lifestyle interventions included psychosocial factors. Response bias was not assessed for the Facebook group, however self-reported PCOS aligned with prevalence of clinical phenotypes and suggests results are generalizable to clinical populations of women with PCOS, who are responsible for self-directing and administering lifestyle interventions to manage their PCOS.
CONCLUSIONS: Perceptions of effectiveness for lifestyle interventions by women with PCOS may be complicated by a lack of rigorous evidence. The strength of recommendations in clinical practice guidelines may be enhanced by clinical trials investigating flexible and feasible lifestyle interventions for women in the community with PCOS.

Entities:  

Keywords:  Exercise; Healthy lifestyle; Polycystic ovary syndrome; Women’s health

Mesh:

Year:  2021        PMID: 33731099      PMCID: PMC7968330          DOI: 10.1186/s12905-021-01252-1

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.809


  31 in total

Review 1.  Environmental and societal factors affect food choice and physical activity: rationale, influences, and leverage points.

Authors:  S L Booth; J F Sallis; C Ritenbaugh; J O Hill; L L Birch; L D Frank; K Glanz; D A Himmelgreen; M Mudd; B M Popkin; K A Rickard; S St Jeor; N P Hays
Journal:  Nutr Rev       Date:  2001-03       Impact factor: 7.110

2.  Physical activity in women with polycystic ovary syndrome: prevalence, predictors, and positive health associations.

Authors:  Julie D Lamb; Erica B Johnstone; Julie-Anne Rousseau; Christopher L Jones; Lauri A Pasch; Marcelle I Cedars; Heather G Huddleston
Journal:  Am J Obstet Gynecol       Date:  2011-02-02       Impact factor: 8.661

3.  Non-response in a survey of cardiovascular risk factors in the Dutch population: determinants and resulting biases.

Authors:  H C Boshuizen; A L Viet; H S J Picavet; A Botterweck; A J M van Loon
Journal:  Public Health       Date:  2005-12-20       Impact factor: 2.427

4.  Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

Authors:  M M Huber-Buchholz; D G Carey; R J Norman
Journal:  J Clin Endocrinol Metab       Date:  1999-04       Impact factor: 5.958

5.  Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome.

Authors:  Melanie Gibson-Helm; Helena Teede; Andrea Dunaif; Anuja Dokras
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

6.  Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.

Authors:  Helena J Teede; Marie L Misso; Jacqueline A Boyle; Rhonda M Garad; Veryan McAllister; Linda Downes; Melanie Gibson; Roger J Hart; Luk Rombauts; Lisa Moran; Anuja Dokras; Joop Laven; Terhi Piltonen; Raymond J Rodgers; Mala Thondan; Michael F Costello; Robert J Norman
Journal:  Med J Aust       Date:  2018-10-01       Impact factor: 7.738

7.  Implementation of dietary and general lifestyle advice among women with polycystic ovarian syndrome.

Authors:  Laura Humphreys; Vassiliki Costarelli
Journal:  J R Soc Promot Health       Date:  2008-07

8.  Dietary intake, physical activity, and obesity in women with polycystic ovary syndrome.

Authors:  C E Wright; J V Zborowski; E O Talbott; K McHugh-Pemu; A Youk
Journal:  Int J Obes Relat Metab Disord       Date:  2004-08

Review 9.  Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan.

Authors:  H Teede; A Deeks; L Moran
Journal:  BMC Med       Date:  2010-06-30       Impact factor: 8.775

10.  Improving the reporting of pragmatic trials: an extension of the CONSORT statement.

Authors:  Merrick Zwarenstein; Shaun Treweek; Joel J Gagnier; Douglas G Altman; Sean Tunis; Brian Haynes; Andrew D Oxman; David Moher
Journal:  BMJ       Date:  2008-11-11
View more
  1 in total

1.  Polycystic ovary syndrome: An exploration of unmarried women's knowledge and attitudes.

Authors:  Eslavath Rajkumar; A Ardra; G Prabhu; Vijyendra Pandey; Jeyavel Sundaramoorthy; Rameez Manzoor; K V Sooraj; M Manikandaprabu; Tukaram Badiger
Journal:  Heliyon       Date:  2022-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.